More setbacks for Biogen: state's largest hospital system spurns Alzheimer's drug
September 29, 2021 at 14:24 PM EDT
The state's largest health care provider has declined to administer Biogen Inc.'s new Alzheimer's drug, citing concerns over its safety and efficacy months after a controversial FDA approval.
